Ken Griffin’s Relay Therapeutics RLAY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-337,268
| Closed | -$884K | – | 6802 |
|
|
2025
Q1 | $884K | Sell |
337,268
-349,610
| -51% | -$916K | ﹤0.01% | 3419 |
|
|
2024
Q4 | $2.83M | Sell |
686,878
-2,222,493
| -76% | -$9.16M | ﹤0.01% | 2259 |
|
|
2024
Q3 | $20.6M | Buy |
2,909,371
+1,746,035
| +150% | +$12.4M | ﹤0.01% | 847 |
|
|
2024
Q2 | $7.58M | Buy |
1,163,336
+926,136
| +390% | +$6.04M | ﹤0.01% | 1399 |
|
|
2024
Q1 | $1.97M | Sell |
237,200
-360,394
| -60% | -$2.99M | ﹤0.01% | 2507 |
|
|
2023
Q4 | $6.58M | Sell |
597,594
-1,085,255
| -64% | -$11.9M | ﹤0.01% | 1487 |
|
|
2023
Q3 | $14.2M | Buy |
1,682,849
+1,374,834
| +446% | +$11.6M | ﹤0.01% | 960 |
|
|
2023
Q2 | $3.87M | Buy |
308,015
+287,296
| +1,387% | +$3.61M | ﹤0.01% | 1890 |
|
|
2023
Q1 | $341K | Sell |
20,719
-113,641
| -85% | -$1.87M | ﹤0.01% | 4192 |
|
|
2022
Q4 | $2.01M | Sell |
134,360
-118,380
| -47% | -$1.77M | ﹤0.01% | 2574 |
|
|
2022
Q3 | $5.65M | Buy |
252,740
+223,821
| +774% | +$5.01M | ﹤0.01% | 1752 |
|
|
2022
Q2 | $484K | Sell |
28,919
-71,175
| -71% | -$1.19M | ﹤0.01% | 4177 |
|
|
2022
Q1 | $3M | Sell |
100,094
-152,665
| -60% | -$4.57M | ﹤0.01% | 2560 |
|
|
2021
Q4 | $7.76M | Buy |
252,759
+66,512
| +36% | +$2.04M | ﹤0.01% | 1698 |
|
|
2021
Q3 | $5.87M | Buy |
186,247
+58,996
| +46% | +$1.86M | ﹤0.01% | 1908 |
|
|
2021
Q2 | $4.66M | Buy |
127,251
+478
| +0.4% | +$17.5K | ﹤0.01% | 2240 |
|
|
2021
Q1 | $4.38M | Buy |
126,773
+63,776
| +101% | +$2.2M | ﹤0.01% | 2253 |
|
|
2020
Q4 | $2.62M | Buy |
62,997
+8,904
| +16% | +$370K | ﹤0.01% | 2305 |
|
|
2020
Q3 | $2.3M | Buy |
+54,093
| New | +$2.3M | ﹤0.01% | 2152 |
|